Formulation and characterization of matrix and triple-layer matrix tablets for oral controlled drug delivery

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 2, Issue 3, 2010, Pages 137-143

  Ahmed, Syed Izhar ^a   Mangamoori, Lakshmi Narsu ^b   Rao, Yamsani Madhusudan ^c  

^a Jayamukhi College of Pharmacy   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

^c KAKATIYA UNIVERSITY   (India)

Author keywords

Diclofenac sodium; Locust bean gum; Triple layer matrix tablets; Xanthan gum

Indexed keywords

ALGAROBA; CARBOXYMETHYLCELLULOSE; DICLOFENAC; EXCIPIENT; LACTOSE; MAGNESIUM STEARATE; STARCH; TALC; XANTHAN;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG GRANULATION; DRUG SOLUBILITY; DRUG STABILITY; HUMIDITY; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; TABLET;

EID: 77954704098     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Colombo P, Conte U, Gazzaniga A, Maggi L, Sangalli M. E and Peppas N. A, et al. Drug release modulation by physical restrictions of matrix swelling. Int. J. Pharm. 1990; 63: 43-48.
2. ® multi-layer matrix tablets containing drugs of different solubility. Biomaterials 1996; 17(9): 889-896.
3. Conte U, Maggi L, Colombo P, and La A Manna. Multi-layered hydrophilic matrices as constant release devices. J. Control. Rel. 1993; 26: 39-47.
4. Yihong Qui and Koplette F. Design of sustained release matrix system for a highly water soluble compound, ABT-089. Int J Pharm 1997; 157: 46-52.
5. Conte U, Colombo P, Maggi L, and Manna La A. Compressed barrier layers for constant drug release in swell able matrix tablets. STP Pharma Sci. 1994; 4:107-113.
6. Yeole PG, Galgatte UC, Babla IB and Nakhat PD. Design and evaluation of Xanthan gum-based sustained release Matrix tablets of Diclofenac sodium. Indian J Pharm Sci 2006; 68:185- 189.
7. Sujja-areevath J, Munday D L, Cox P J. Khan K A. Relationship between swelling, erosion and drug release in hydrophilic natural gum mini matrix formulation. Eur. J. Pharm; 1998; 6: 207-217.
8. Talukdar MM and Vercammen JP. Evaluation of xanthan gum as a hydrophilic matrix for controlled release dosage forms. Drug Dev Ind Pharm 1993; 19:1037-1046.
9. Billa N and Yuen KH. Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS Pharm Sci Tech 2000; 1:35-42.
10. Munday DL and Cox PJ. Compressed Xanthan and Karaya gum matrices: hydration, erosion and drug release mechanisms. Int J Pharm 2000; 203:179-92.
11. Dea I.C.M and Morrison A. Chemistry and interaction of seed galactomannans. Adv Carbohydrates chemistry and biochemistry. 1975; 31: 242-312.
12. Robinson M.H.E, Wheatley T and Leach I. Non steroidal anti inflammatory drug-induced colonic stricture. Digest. Dis. Sci. 1995; 40: 315-319.
13. Gonazalez -Rodriguez ML. In vitro release of sodium Diclofenac from central core matrix tablet aimed for colonic drug delivery. Eur. J. Pharm. Sci. 2003; 20(1):125-31.
14. Swabricks J and Boylan JC. Controlled and modulated-release drug delivery system. Ed Chein Y. W, Encyclopedia of Pharmaceutical technology, Vol- 3, Marcel Decker Inc, New York 1991. p. 286-289.
15. Gohel MC and Panchal M.K. Novel use of similarity factors f2 and Sd for the development of diltiazem HCl modified-release tablets using a 3(2) factorial design. Drug Dev. Ind. Pharm 2002; 28(1): 77-87.
16. Banakar UV, Pharmaceutical Dissolution Testing, 1st ed. Marcel Decker Inc, New York 1992. p. 191-194.
17. Mathews BR., Regulatory aspects of stability testing in Europe, Drug Dev Ind. Pharm 1999; 25: 831-856.
18. Williams RO, Reynolds TD, Cabelka TD, Sykora MA, and Mahaguna V. Investigation of excipeints type and level on drug release from controlled release tablets Containing HPMC. Pharm. Dev.Tech 2002; 7, 2 181-190.
19. Krishnaiah YSR, Karthikeyan RS and Satyanarayana V. A three- layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate. Int J. Pharm 2002; 241: 353-366.